Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells

Citation
S. Kochi et al., Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells, EUR J PHARM, 372(3), 1999, pp. 287-295
Citations number
38
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
372
Issue
3
Year of publication
1999
Pages
287 - 295
Database
ISI
SICI code
0014-2999(19990521)372:3<287:EOCAOT>2.0.ZU;2-4
Abstract
Recently, it has been reported that continuous treatment with cyclosporin A or tacrolimus induces encephalopathy in transplant patients. The mechanism of immunosuppressant-induced encephalopathy is unclear. We investigated th e cytotoxicity to brain capillary endothelial cells and the effect of these two drugs on P-glycoprotein function using mouse brain capillary endotheli al (MBEC4) cells. The transcellular transport of [H-3]sucrose was significa ntly increased and the cellular viability, based on 3-(4, 5-dimethylthiazol -2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay and trypan blue exclus ion test, was decreased by cyclosporin A (approximately 50% at 5 mu M; P < 0.005), while tacrolimus showed a much smaller effect. These findings indic ate that the toxicity of cyclosporin A was greater than that of tacrolimus. The uptake of [H-3]vincristine, a substrate of P-glycoprotein, was increas ed by these two drugs. The expression of P-glycoprotein in MBEC4 cells was reduced, but there was no effect on mdr1b mRNA levels. The decrease in the expression of P-glycoprotein may be due to the inhibition of the turnover o f P-glycoprotein, which involves translation. In conclusion, the direct cyt otoxic effect on the brain capillary endothelial cells and the inhibition o f P-glycoprotein may be partly involved in the occurrence of immunosuppress ant-induced encephalopathy. (C) 1999 Elsevier Science B.V. All rights reser ved.